Css LLC Amicus Therapeutics, Inc. Transaction History

Css LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $186,125 - $482,711	-20,231 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $67,350 - $124,450	5,000 Added 32.83%	20,231 $467,000
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $196,327 - $242,020	15,231 New	15,231 $215,000
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $150,706 - $253,677	-22,731 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$7.48 - $10.75 $56,100 - $80,625	-7,500 Reduced 24.81%	22,731 $221,000
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $207,726 - $343,188	-25,901 Reduced 46.14%	30,231 $242,000
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $601,035 - $789,681	54,839 Added 4241.22%	56,132 $701,000
Q1 2019 May 15, 2019	BUY	$10.04 - $13.92 $12,981 - $17,998	1,293 New	1,293 $18,000

312

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.